posted on 1997-08-22, 00:00authored byCarl R. Johnson, Brian A. Johns
The synthesis of 11
β-1-C-aryl-deoxymannojirimycin analogues using a versatile
de novo strategy
is described. The origins of this report are derived from several
recent developments in the area
of C1-substituted glycomimetic polyhydroxylated
piperidines. This study is designed as a structure−activity comparison to explore the effects of aryl substitution on the
ability of the title compounds
to inhibit glycosidase enzymes. The polyhydroxylated piperidine
ring was constructed using vinyl
bromide 10, which was synthesized in six steps from the
bromobenzene microbial oxidation
metabolite bromo diol 9. A palladium-catalyzed Suzuki
cross-coupling of vinyl bromide 10 and the
corresponding arylboronic acid served as the key pseudoanomeric
carbon−carbon bond-forming
step. Ozonolysis and selective reduction of the resultant carbonyl
functions followed by reductive
amination served to produce the azasugar ring. The complete NMR
analysis of the resultant
piperidine ring stereochemistry is also discussed. Fully
deprotected β-1-C-aryl-deoxymannojirimycin
analogues 8·HCl were obtained upon acidic
deprotection.